Corcept Therapeutics
- Active openings
- 20+
- US-based roles
- 0
- Remote-friendly
- 0
- Last updated
- 2026-10-03
What Corcept Therapeutics is hiring for
Open positions
20+ active- Senior Director, Clinical PharmacologyOct 3
- Associate Director, Patient Safety & Pharmacovigilance ScienceOct 3
- Manager, PharmacokineticsOct 3
- Clinical Sales Specialist (CS) - Birmingham, ALOct 3
- Senior Manager, Marketing (Peer to Peer Education)Oct 2
About Corcept Therapeutics
Claim to unlockMission, culture, and benefits - visible once this page is claimed and verified.
Updates
Prevalence of Hypercortisolism in Individuals With Resistant Hypertension and Cardiovascular Disease
Prevalence of Endogenous Hypercortisolism in Individuals With Resistant Hypertension Stratified by Kidney Function: Results From the MOMENTUM Study
Efficacy and Safety of Relacorilant + Nab-paclitaxel in Patients Aged ≥65 Years With Platinum-resistant Ovarian Cancer (PROC) in the Phase 3 ROSELLA Study (GOG-3073, ENGOT-OV72, APGOT-Ov10)
Real-World Comparative Effectiveness of Nab-paclitaxel and Standard of Care Chemotherapies in Patients With Platinum-Resistant Ovarian Cancer (COMPASS 2.0)
Endogenous Hypercortisolism in Individuals With Resistant Hypertension and Difficult-to-Control Type 2 Diabetes: Results From Two Large, Prospective Studies
Characterization of Individuals With Resistant Hypertension and Post-Dexamethasone Suppression Test Cortisol 1.8 μg/dL: Results From the MOMENTUM Study